Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGINTERVENTIONAL

Sustained Endogenous Attention Deficits in Attention Deficit Hyperactivity Disorder

Evaluation of Sustained Endogenous Attention Deficits in Attention Deficit Hyperactivity Disorder: Validation of a Computerized Neuropsychological Test."

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Subjects with ADHD may exhibit deficits in sustained internal attention. The "Sustained-Paced Finger Tapping" test was recently developed and experimentally used in international literature to assess sustained internal attention in typically developing children. This clinical study has several objectives: 1) to assess the presence of "internal" sustained attention deficits in children with ADHD through the "Sustained-Paced Finger Tapping"; 2) to evaluate the discriminant and ecological validity of the "Sustained-Paced Finger Tapping."

Who May Be Eligible (Plain English)

Who May Qualify: - ADHD Group (1) Subjects with a diagnosis of ADHD of any severity level and subtype - ADHD Group (2) "Medication-naive" ADHD subjects, meaning subjects who have not been prescribed and/or have not yet started any pharmacological treatment for ADHD - ADHD Group (3) IQ ≥ 70 - Non-ADHD Group, Normal IQ Who Should NOT Join This Trial: - for both groups, symptomatology suggestive of autism spectrum disorders, psychotic disorders, mood disorders, and anxiety disorders - for both groups, use of psychotropic drugs - for both groups, subjects with cerebral palsy and/or neuromotor and neuromuscular disorders - for both groups, CNS diseases, e.g., epilepsy and/or neurodegenerative diseases, or central nervous system injuries resulting from, for example, head trauma or stroke - for the non-ADHD group, presence of ADHD symptoms Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * ADHD Group (1) Subjects with a diagnosis of ADHD of any severity level and subtype * ADHD Group (2) "Medication-naive" ADHD subjects, meaning subjects who have not been prescribed and/or have not yet started any pharmacological treatment for ADHD * ADHD Group (3) IQ ≥ 70 * Non-ADHD Group, Normal IQ Exclusion Criteria: * for both groups, symptomatology suggestive of autism spectrum disorders, psychotic disorders, mood disorders, and anxiety disorders * for both groups, use of psychotropic drugs * for both groups, subjects with cerebral palsy and/or neuromotor and neuromuscular disorders * for both groups, CNS diseases, e.g., epilepsy and/or neurodegenerative diseases, or central nervous system injuries resulting from, for example, head trauma or stroke * for the non-ADHD group, presence of ADHD symptoms

Treatments Being Tested

DIAGNOSTIC_TEST

Sustained-Paced Finger Tapping" (Petilli et al., 2018)

Sustained-Paced Finger Tapping" (Petilli et al., 2018) a computerized test that lasts approximately 10 minutes. It involves maintaining and reproducing the rhythm of a sound (auditory version).

Locations (2)

Associazione "La Nostra Famiglia"-IRCCS "E. Medea"-Scientific Hospital for Neurorehabilitation-Unit for Severe Disabilities in Developmental Age and Young Adults (Developmental Neurology and Neurorehabilitation)
Brindisi, Italy
Università del Salento
Lecce, Italy